A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among people with obesity. A new clinical trial has found that tirzepatide, sold under the name Zepbound, led to significantly…
New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
